Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly in developed countries. Although pathogenic factors, such as oxidative stress, inflammation and genetics are thought to contribute to the development of AMD, little is known about the relationships and priorities between these factors. Here, we show that chronic photo-oxidative stress is an environmental factor involved in AMD pathogenesis. We first demonstrated that exposure to light induced phospholipid oxidation in the mouse retina, which was more prominent in aged animals. The induced oxidized phospholipids led to an increase in the expression of monocyte chemoattractant protein-1, which then resulted in macrophage accumulation, an inflammatory process. Antioxidant treatment prevented light-induced phospholipid oxidation and the subsequent increase of monocyte chemoattractant protein-1 (also known as C-C motif chemokine 2; CCL2), which are the beginnings of the light-induced changes. Subretinal application of oxidized phospholipids induced choroidal neovascularization, a characteristic feature of wet-type AMD, which was inhibited by blocking monocyte chemoattractant protein-1. These findings strongly suggest that a sequential cascade from photic stress to inflammatory processes through phospholipid oxidation has an important role in AMD pathogenesis. Finally, we succeeded in mimicking human AMD in mice with low-level, long-term photic stress, in which characteristic pathological changes, including choroidal neovascularization formation, were observed. Therefore, we propose a consecutive pathogenic pathway involving photic stress, oxidation of phospholipids and chronic inflammation, leading to angiogenesis. These findings add to the current understanding of AMD pathology and suggest protection from oxidative stress or suppression of the subsequent inflammation as new potential therapeutic targets for AMD.
Introduction
Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly in developed countries (Beatty et al., 2000) . AMD is a progressive, polygenic and multifactorial disease with a poorly understood etiology, although numerous studies have suggested the involvement of factors such as oxidative stress, inflammation, immune response and genetics in the onset of AMD (Baba et al., 2010; Edwards et al., 2005; Grossniklaus et al., 2002; Haines et al., 2005; Klein et al., 2005; Yates et al., 2007) .
Some age-related diseases can have pathologically common molecular mechanisms, and we focused on the histopathological similarities between AMD and atherosclerosis. We previously demonstrated that photoreceptor phospholipids in the macula are more oxidized in eyes with AMD than in age-matched normal eyes and that accumulated macrophages in AMD lesions express scavenger receptors for oxidized phospholipids . Other studies analyzing human eyes with AMD also suggest the involvement of lipid uptake (Malek et al., 2003) and an immune response to oxidized lipids produced by oxidative stress (Hollyfield et al., 2008) . Oxidized phospholipids stimulate the expression of vascular endothelial growth factor (VEGF) (Bochkov et al., 2006) , which induces inflammatory gene expression (Furnkranz et al., 2005) as well as neovascularization. The detailed mechanisms underlying the involvement of oxidized phospholipids in AMD, however, remain unknown. Therefore, in the present study, we examined the involvement of oxidized phospholipids in AMD pathogenesis and compared our findings with the pathogenic mechanisms of atherosclerosis.
AMD affects the macula, the center area of the retina, where light is focused throughout life. We hypothesized that light causes oxidative stress to the macula. Although there are numerous reports that intensive light irradiation causes retinal damage, known as phototoxicity, we evaluated low-intensity, long-term light exposure as an enhanced model of the effects of light in daily life.
In this paper, we propose a pathogenic pathway from light exposure to choroidal neovascularization (CNV) formation, a characteristic feature of AMD, involving oxidative stress and chronic inflammation.
Results

Light induces phospholipid oxidation in the retina
We first investigated whether subacute mid-level light exposure (1000 lux for 1 week; Fig. 1A ) induces lipid oxidation in the retina. After exposing the mouse retinas to light, mass spectrometry analyses revealed a significant increase in 9-oxononanoic acid esters of 2-lyso-phosphatidylcholine (ON-PC; P,0.001), 4,7-dioxohept-6-enoic acid esters of 2-lysophosphatidylcholine (KOHA-PC; P50.037) and succinic acid esters of 2-lyso-phosphatidylcholine (S-PC; P50.006), and no changes in azeleic acid esters of 2-lyso-phosphatidylcholine (A-PC; P50.642), 4-hydroxy-7-oxohept-5-enoic acid esters of 2-lyso-phosphatidylcholine (HOHA-PC; P50.533) and 4-oxobutyric acid esters of 2-lyso-phosphatidylcholine (OB-PC; P50.812; Fig. 1B) . Therefore, ON-PC was used as a representative oxidized phospholipid. Oxidized phospholipids were observed in the retinas of untreated normal animals Fig. 1 . Blue-light irradiation induces phospholipid oxidation in the retina. (A) Light exposure apparatus. Freely moving mice were exposed to blue light using an LED with a transmission peak wavelength of 480 nm and an intensity of 1000 lux for the subacute experiments, and 500 lux for the chronic experiments. (B) Some oxidized phosphatidylcholine species significantly increased in the light-irradiated retinas. Of the linoleic acid esters of 2-lyso-PC, ON-PC (9-oxononanoic acid ester of 2-lyso-phosphatidylcholine) significantly increased (P,0.001) after light exposure (1000 lux, continuously 1 week). Of the docosahexaenoic acid esters of 2-lyso-PC, KOHA-PC (4,7-dioxohept-6-enoic acid esters of 2-lyso-phosphatidylcholine) and S-PC (succinic acid esters of 2-lysophosphatidylcholine) showed significant increases (P50.037 and 0.006) after light exposure. A-PC, azeleic acid esters of 2-lyso-phosphatidylcholine; HOHA-PC, 4-hydroxy-7-oxohept-5-enoic acid esters of 2-lyso-phosphatidylcholine; OB-PC, 4-oxobutyric acid esters of 2-lyso-phosphatidylcholine. (C-F) Immunohistochemistry for oxidized phospholipids (ON-PC). Oxidized phospholipids (red) are present throughout the sensory retina, RPE and choroid, and seem more prominent in 12-month-old mice (E) than in 2-month-old mice (C). Light irradiation increased immunostaining in both 2-month-old (D) and 12-monthold (F) mice. Interestingly, oxidized phospholipids in the outer plexiform layer, the photoreceptor outer segments, RPE and choroid were more apparent in the older mice (D) than in the younger mice (F). GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PR, photoreceptor outer segments; RPE, retinal pigment epithelium. Scale bars: 50 mm. (G) Relative amounts of oxidized phospholipids in the retinas were evaluated with competitive ELISA. Oxidized phospholipids increased 2.2-and 2.3-fold in the retinas of 2-and 12-month-old irradiated mice, respectively, when compared with non-irradiated mice. There were 1.7-fold more (P50.003) oxidized phospholipids in the 12-month-old irradiated retinas than in the 2-month-old irradiated retinas. There was no significant difference between 2-month-old and 12-month-old control retinas. 2M, 2-month-old mice; 12M, 12-month-old mice. Values are means 6 s.d., n510 mice per group. **P,0.001; *P50.003; n.s., no significance. (Fig. 1C,E) , but seemed more prominent in aged animals ( Fig. 1E) , and they were distributed over the entire sensory retina from the nerve fiber layer to the photoreceptor outer segments, the retinal pigment epithelium (RPE) and the choroid. Light irradiation increased immunostaining for oxidized phospholipids in the retinas of both 2-month-old and 12-monthold mice (Fig. 1D,F) . Oxidized phospholipids in the outer plexiform layer, the photoreceptor outer segments, the RPE and the choroid were more prominent in the older mice (Fig. 1F ) than in the younger mice (Fig. 1D) . A competitive enzyme-linked immunosorbent assay (competitive ELISA) revealed a significant increase in oxidized phospholipids in the retinas of irradiated mice compared with non-irradiated mice in both 2-month-old and 12-month-old mice (P,0.001; Fig. 1G ). Irradiated older mice had significantly more oxidized phospholipids than irradiated younger mice (P50.003). Although the sleep duration of irradiated mice was not monitored closely, there was not the obvious interruption of the normal sleep pattern because they did not show any weight loss, epilation, abnormal behavior and early mortality compared with control mice. Thus, photic stress induced phospholipid oxidation in the retina, and older animals were more susceptible to photic stress than younger animals.
Monocyte chemoattractant protein-1 is induced by oxidized phospholipids in RPE cells and by light irradiation in the retina in vivo
We next investigated reactions induced by phospholipid oxidation in the retina. We examined whether oxidized phospholipids induce monocyte chemoattractant protein-1 (MCP-1; also known as C-C motif chemokine 2; CCL2), an important chemotactic factor for macrophages (Lu et al., 1998) , which have a key role in human AMD (Grossniklaus et al., 2002) . Both oxidized (ON-PC) and nonoxidized [1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine (PL-PC)] phospholipids, increased the amount of MCP-1 protein released by RPE cells in a dose-dependent manner. RPE cells released more MCP-1 following treatment with oxidized phospholipids compared with non-oxidized phospholipids (concentrations up to 50 mg/ml; Fig. 2A ). In the in vivo analysis, MCP-1 mRNA and protein significantly increased after light irradiation in both 2-month-old and 12-month-old mice (P,0.001; Fig. 2B ,C). The increase was more evident in older mice. MCP-1 immunostaining in the RPE was notable in the retinas of light-irradiated 12-month-old mice, whereas there was no apparent staining in non-irradiated retinas (Fig. 2D ). Macrophages accumulated in the choroid of the 12-month-old MCP-1 mRNA levels were undetectable in the non-irradiated 2-month-old mice, but in the light-irradiated 2-month-old mice, the MCP-1 mRNA level was 0.51% relative to the b-actin mRNA level. MCP-1 mRNA levels increased in the lightirradiated 12-month-old mice compared with the non-irradiated 12-month-old mice. Values are means 6 s.d., n56 mice per group. **P,0.001, *P50.003 compared with non-irradiated mice. (C) MCP-1 protein also showed a significant increase after light irradiation. In the non-irradiated 2-month-old mice, the MCP-1 protein was undetectable with ELISA, but in the light-irradiated 2-month-old mice, the MCP-1 protein level was 6.62 pg/mg total protein. MCP-1 protein levels increased in the 12-month-old light-irradiated mice compared with the non-irradiated 12-month-old mice. Values are means 6 s.d., n56 mice per group. *P,0.001 compared with non-irradiated mice. (D) Immunohistochemistry for MCP-1 in the eye with light irradiation. MCP-1 signals (green) are observed in the RPE of 12-month-old light-irradiated mouse retinas. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PR, photoreceptor outer segments; RPE, retinal pigment epithelium. (E) Light-irradiation-induced macrophage accumulation in the choroid. The immunoreactivity for F4/80 increased in the choroid of the 12-month-old mice after light irradiation (500 lux) for 2 months (right), whereas no immunoreactivity were detected in the non-irradiated 12-month-old mice (left). Scale bars: 50 mm.
mice after long-term, low-intensity light irradiation (500 lux for 2 months; Fig. 2E ). These findings suggest that photo-oxidative stress induces the expression of MCP-1 through the oxidation of phospholipids, which have an important role in inducing inflammation, especially in older animals.
Oxidized phospholipids induce CNV
To confirm that the cascade of reactions subsequent to photooxidative stress has an important role in AMD development, oxidized phospholipids (ON-PC) or non-oxidized phospholipids (PL-PC) were injected into the subretinal space of wild-type mice. Although CNV was not observed in the control eyes injected with non-oxidized phospholipids (Fig. 3A) , all eyes receiving oxidized phospholipids exhibited apparent CNV formation within 4 weeks of the subretinal injection (Fig. 3B ).
Oxidized phospholipids induce CNV in retinas of wild-type mice but not in retinas of MCP-1 and MCP-1 receptor knockout mice
We then injected oxidized phospholipids into the subretinal space of two different knockout (KO) mouse lines, MCP-1 2/2 (Ccl2 2/2 ) and C-C chemokine receptor type 2 (Ccr2 2/2 ; MCP-1 receptor), to examine the involvement of the MCP-1 pathway in CNV formation. CNV did not develop after subretinal injections of oxidized phospholipids into MCP-1 2/2 (Fig. 3D) or Ccr2 2/2 mice (Fig. 3F) , whereas CNV developed in the eyes of their wild-type siblings (Fig. 3B) . CNV was not observed in any eyes injected with non-oxidized phospholipids (Fig. 3A,C,E) . These results indicated that activation of the MCP-1 pathway by oxidized phospholipids has a pivotal role in CNV formation in vivo.
Long-term, low-intensity photo-oxidative stress induces basal laminar deposits, macrophage accumulation and CNV formation
The results of the above experiments confirmed that the cascade from photic stress to MCP-1 activation involving phospholipid oxidation in the retina could have a pivotal role in CNV formation in vivo. We, therefore, attempted to mimic human AMD in mice using long-term, low-level light irradiation. Basal laminar deposits, an essential histopathological feature of AMD, were observed in the eyes of animals exposed to low-level bluelight irradiation (500 lux) every 2 days for 4 to 6 months ( Fig. 4A) . Subsequently, in four of eight eyes, CNV was observed in the fundus (Fig. 4B) . Fluorescein angiography revealed that the CNV was the occult-dominant type (Fig. 4C) , the major CNV type observed in human AMD, with typical histopathological features of CNV in human AMD, including a thickened and proliferated vascular lesion between the RPE and Bruch's membrane (Fig. 4D) . Electron microscopic and immunohistochemical examinations showed that macrophages accumulated around the CNV and engulfed the photoreceptor outer segments, including the oxidized phospholipids (Fig. 4E) , as observed in human CNV lesions (Lu et al., 1998) . The lack of CNV in both MCP-1 2/2 (n54) and Ccr2 2/2 mice (n56) under the same irradiating conditions confirmed that the MCP-1 pathway is involved in CNV development induced by longterm low-intensity light irradiation (Fig. 4F) .
Prevention of oxidative changes and MCP-1 induction by a-phenyl-N-tert-butylnitrone
To confirm that oxidative stress itself is the cause of lightinduced changes, a-phenyl-N-tert-butylnitrone (PBN), an antioxidant, was daily injected intraperitoneally into 12-monthold mice during light irradiation (1000 lux for 1 week). PBN ( Fig. 5C ) suppressed the higher level of oxidized phospholipids that occur after light irradiation (Fig. 5A,B) . The light-induced increases of MCP-1 immunoreactivity (Fig. 5D,E) , mRNA ( To investigate whether VEGF, a major angiogenic cytokine, and pigment epithelium-derived factor (PEDF), a potent angiogenic inhibitor, are involved in CNV formation by long-term, lowintensity light exposure, the expression of VEGF and PEDF were examined in light-induced CNV. Strong VEGF immunoreactivity was detected in light-induced CNV lesions (Fig. 6A) , where strong VEGFR2 immunoreactivity was also detected (Fig. 6B) . PEDF immunoreactivity was weak in light-induced CNV lesions (Fig. 6C) . Next, we examined whether RPE-derived MCP-1 mediates the expression of VEGF and PEDF. RPE cells released VEGF with both oxidized and non-oxidized phospholipids in a dose-dependent manner, and more VEGF was released following treatment with oxidized phospholipids than with non-oxidized phospholipids (concentrations 10, 25 and 50 mg/ml, P,0.001; Fig. 6D ). These elevated VEGF levels were significantly decreased by MCP-1 siRNA treatment (P,0.05, n56; Fig. 6D ). PEDF protein levels did not differ significantly in RPE cells treated with either oxidized or non-oxidized phospholipids (concentrations 10, 25 and 50 mg/ml). MCP-1 siRNA treatment did not affect PEDF production following treatment with either oxidized or non-oxidized phospholipids (Fig. 6E ).
Discussion
The development of an AMD animal model following long-term, low-intensity light exposure in the present study suggests that light exposure is an environmental factor that contributes to AMD pathogenesis. Light exposure inevitably causes oxidative stress to the retina, especially in modern life, as we are surrounded by artificial lights such as indoor illumination, computer monitors and television. Some epidemiological studies suggest that light exposure is linked to AMD (Cruickshanks et al., 1993; Taylor et al., 1992) , while others do not (Clemons et al., 2005) . Even the study finding no apparent link between light exposure and AMD development did report that low levels of dietary antioxidants, including lutein and vitamin C, are associated with an increased risk for AMD, which is supported by other studies (SanGiovanni et al., 2007; Tan et al., 2008; van Leeuwen et al., 2005) . The present findings demonstrated that exposure to blue light induces oxidative stress and chronic inflammation, which are more prominent in aged animals. These effects seem to be due to light directly but not due to the interruption of the normal sleep pattern by conitinuous irradiation because the mice in the experiments probably have a normal sleep-wake pattern. In addition, these changes are suppressed by an antioxidant. This suggests that AMD is more likely to develop in people who are more susceptible to oxidative stress because of decreased antioxidant activity or in people who have an exaggerated immune response to oxidized products.
Our results also demonstrate that elevated VEGF expression caused by oxidized phospholipids in RPE cells is suppressed by MCP-1 siRNA. Therapeutic strategies to protect phospholipids from photic stress-induced oxidation or to suppress the subsequent inflammation induced by biologically active lipid peroxidation products warrant further investigation. The present study suggests that photic stress induces MCP-1 through the oxidation of phospholipids in the retina, which might have an important role in inducing inflammation in AMD pathogenesis. The mechanism of the oxidized phospholipidmediated inflammatory response plays an important role in other age-related diseases, including atherosclerosis (Bochkov et al., 2006) , where MCP-1 plays a key pathogenic role. In the current study, knockout of MCP-1, or its receptor, CCR-2, in mice did not result in obviously features of AMD, including drusen, which are deposits of a protein-lipid complex, photoreceptor atrophy and CNV, as previously reported (Ambati et al., 2003) , although in wild-type, MCP-1 KO and CCR-2 KO mice, the white spots increased with age at the same level. The role of MCP-1 in AMD pathogenesis is controversial; some research groups reported that downregulation of MCP-1 suppressed CNV formation (Yamada et al., 2007) , whereas others showed the AMD-like phenotype in Ccl-2 (MCP-1) KO mice (Ambati et al., 2003) . The former demonstrated that the downregulation of MCP-1 decreased CNV size through a reduction of macrophage infiltration, whereas the latter showed that MCP-1 deficiency caused less macrophage accumulation and allowed accumulation of complement component 5a (C5a) and IgG, which induces VEGF production by RPE and provides an environment permissive for CNV. Mice deficient in Ccl-2 and/or C-X3-C chemokine receptor 1 (Cx3cr1) with aberrant MCP-1 signaling show retinal angiomatous proliferation, a type of CNV in AMD (Zhou et al., 2011) . Considering these previous reports and our current study together, we speculate that MCP-1 impairment can serve both pro-and anti-angiogenesis roles depending on the circumstances.
The findings of the present study make an important contribution to AMD research by providing an animal model that mimics the human disease. Mimicking human CNV in model animals has been difficult to date. Laser-induced CNV is currently the only widely used model. The CNV in the laserinduced model, however, is pathologically different from human CNV because it produces a granuloma resulting from the trauma induced by a laser intense enough to rupture Bruch's membrane located between the RPE and the choroid, and represents only classic CNV, which is not a major type of CNV such as occultdominant CNV in humans. Although the CNV model in this study requires aged animals and several months of light exposure, it more closely resembles the human pathology than the laserinduced CNV animal models, which will cosiderably advance the development of new treatments for AMD. 
Materials and Methods
Animals
MCP-1
2/2 mice backcrossed to a C57BL/6 background were purchased from the Jackson Laboratory (Bar Harbor, ME). Ccr2 2/2 mice with a 129xB6 background were generated as described previously (Boring et al., 1997) . Littermates were used as controls in each experiment. All experiments were performed in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research.
Light exposure
Freely moving 2-month-old and 12-month-old C57BL/6 male mice were exposed to a blue light-emitting diode (LED) continuously for 1 week (Moritex, Tokyo, Japan; illuminance: 1000 lux, transmission peak wavelength: 480 nm). For lowlevel light irradiation, freely moving 6-month-old wild-type, MCP-1 2/2 and Ccr2 2/2 mice were exposed to a blue LED every 2 days for 6 months (Moritex; illuminance: 500 lux, transmission peak wavelength: 480 nm; Fig. 1A ). They were maintained on a 12-hour:12-hour light:dark cycle of dim overhead fluorescent light in the whole room.
Mass spectrometric analysis of phospholipids
Lipid extracts were re-dissolved in methanol:water (90:10) and liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS-MS) performed using a Prodigy ODS C18 column for separation of the lipids and the HPLC solvent system (Waters, Milford, MA). Mass spectrometric analyses were performed using ESI-MS-MS in the positive ion, multiple reaction monitoring (MRM) mode (cone energy 30 V, collision energy 25 eV). The MRM transitions used to detect individual oxidized phospholipids were the mass to charge ratio (m/z) for the molecular cation [M+H] + and their daughter ion 184, the phosphatidylcholine group. Calibration curves for quantitative analyses of individual oxidized phosphatidylcholine molecular species were constructed by mixing a fixed amount of internal standard (ditetradecyl phosphatidylcholine) into various amounts of authentic oxidized phosphatidylcholine samples (Sun et al., 2006) .
Immunohistochemistry
Enucleated mouse eyes were immersed in ice-cold phosphate-buffered 4% paraformaldehyde for 6 hours. Eyes were infiltrated with 30% sucrose and embedded in OCT compound (Sakura Finetechnical Co., Tokyo, Japan). Sections (8 mm) were cut, air-dried for 3 hours, and stored at 280˚C. Standard protocols were used for immunofluorescent staining with digitonin permeabilization. Briefly, sections blocked with 5% normal donkey serum were incubated overnight at 4˚C with mouse monoclonal antibody to human oxidized phosphatidylcholine, DLH3 [1:100; provided by Hiroyuki Itabe (Itabe et al., 1994) ], goat polyclonal antibody to mouse MCP-1 (1:100; R&D Systems, Minneapolis, MN), rat monoclonal antibody to F4/80 (1:100; Serotec), rabbit polyclonal antibody to mouse PEDF (1:100; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), rabbit polyclonal antibody to mouse VEGF or VEGFR2 (1:100; Abcam, Cambridge, UK). Slides were washed three times with Tris-buffered saline containing 0.1% Tween 20 and incubated with Alexa-Fluor-546-or Alexa-Fluor-488-conjugated secondary antibodies (Invitrogen, Carlsbad, CA) for 60 minutes at room temperature.
Competitive ELISA for oxidized phospholipids
Relative amounts of oxidized phospholipids in the retinas were evaluated using a competitive enzyme-linked immunosorbent assay (ELISA) as described in a previous report (Itabe et al., 1994) , which is a modified sandwich ELISA procedure for determining oxidized low density lipoprotein (OxLDL). Briefly, microtiter wells precoated with the monoclonal antibody, DLH3 (5 mg/ml in PBS; 100 ml/well) were blocked with 1% bovine serum albumin in 50 mM Tris-buffered saline, pH 8.0. A solution of lipids (100 ml) extracted from retinas, which were resuspended in PBS, was placed in each well and left at room temperature for 30 minutes, followed by the addition of 10 ml OxLDL (1 mg/ml). The OxLDL that remained after washing with Tris-buffered saline containing 0.05% Tween 20 was detected using 100 ml sheep anti-human apoB IgG (Chemicon, Temecula, CA) and 100 ml alkaline-phosphatase-conjugated donkey anti-sheep IgG antibody (Chemicon). Alkaline phosphatase reactivity was measured by incubating 1 mg/ml of p-nitrophenylphosphate at 37˚C for the appropriate time intervals. Antigenic activity was expressed as a percentage of inhibition, calculated as [Abs (OxLDL)2Abs (sample + OxLDL)] 6100/[Abs (OxLDL)2Abs (PBS)].
Lipids
Oxidized phospholipids [ON-PC; 9-oxononanoic acid esters of 2-lysophosphatidylcholine (2-lyso-PC)] and phospholipids (PL-PC; linoleic acid) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL).
Cell culture
The human retinal pigment epithelial cell line ARPE-19 was obtained from the American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium-F-12 supplemented with 10% fetal bovine serum, penicillin (100 U/ml) and streptomycin sulfate (100 mg/ml). Cells were grown at 37˚C in humidified 5% CO 2 and split twice a week when approximately 90% confluent. Cells were obtained at passage 12 and used at passages 14 to 18. RPE cells were subcultured in 24-well tissue culture plates at a density of 4610 4 cells/well. Seven days after reaching confluency, the medium was changed and cells were incubated in serumfree Dulbecco's modified Eagle's medium in the presence or absence of untreated phospholipids or oxidized phospholipids at concentrations of 0, 10, 25, or 50 mg/ ml. After 6 hours, the medium was collected, filter sterilized, and stored at 280˚C until used for ELISA of MCP-1. Each condition was evaluated in triplicate, and experiments were repeated at least three times independently.
Real-time RT-PCR for MCP-1
For analysis of MCP-1 mRNA levels in the retina-RPE-choroid complex, total RNA was isolated from the respective samples (RNeasy Mini Kit, Qiagen Inc., Valencia, CA) and reverse-transcribed with a cDNA synthesis kit (First-Strand, Amersham Biosciences/GE Lifesciences; Piscataway, NJ). We used b-actin as the invariant control. Commercially available primers and probe sets of the mouse MCP-1 genes (Invitrogen) were prepared for the analysis. We performed amplification, detection, and data analysis using the ABI PRISM 7900 Sequence Detection System.
ELISA
The retina-RPE-choroid complex was placed into 200 ml lysis buffer supplemented with protease inhibitors and sonicated. The lysate was centrifuged at 21,880 g for 10 minutes at 4˚C. The supernatants and amount of secreted MCP-1,VEGF or PEDF in the conditioned medium from RPE cells were assayed with ELISA kits for MCP-1, VEGF (R&D Systems) and PEDF (BioVendor, Czech Republic) according to the manufacturers' protocols. Protein concentrations were determined using the BCA protein assay kit (Pierce, Rockford, IL).
Subretinal injection of oxidized phospholipids or non-oxidized phospholipids
Subretinal injections were performed on 8-week-old C57BL/6J, MCP 2/2 and Ccr2 2/2 mice. The mice received phospholipids (50 mg/ml) in one eye and oxidized phospholipids (50 mg/ml) in the other eye. At this concentration, there was no significant difference in the survival of ARPE-19 cells after exposure to oxidized phospholipids and phospholipids. Pulled glass micropipettes were calibrated to deliver 2 ml of vehicle upon depression of a foot switch (FemtoJet Express; Eppendorf). The mice were anesthetized with ketamine hydrochloride (100 mg/kg body weight) and xylazine (10 mg/kg body weight), pupils were dilated with topical 1% tropicamide (Santen Inc., Napa, CA), and the sharpened tip of the micropipette (Eppendorf) was passed through the sclera 1 mm posterior to the limbus and positioned adjacent to the retina. Depression of the foot switch caused the injection fluid to penetrate the retina. Injections were performed using a condensing lens system, which allowed visualization of the retina during the injection. This technique is atraumatic and the direct visualization confirmed a successful injection by the appearance of a small retinal bleb. All injections were made at a site approximately two-thirds of the distance vertically from the optic disc to the ora serrata in the superior retina.
Histology examination
For histology, the eyes were enucleated and fixed with 4% paraformaldehyde for 1 hour at 4˚C. After removing the anterior segment, the eyecups were fixed again in 4% paraformaldehyde overnight, dehydrated in 30% sucrose for 6 hours, and then embedded in Tissue-TekH OCT compound. The eyecups were sectioned into 7-mm thick slices and stained with Hematoxylin and Eosin.
Electron microscopy
The retina-RPE-choroid was fixed in 2.5% glutaraldehyde solution for 2 hours and 1% osmium tetroxide solution for 1 hour, rinsed in PBS, dehydrated in ethanol, and then embedded in epoxy resin (Nissin EM Quetor 812). Thick (1.0 mm) and ultrathin sections (80 nm) were cut on a ultramicrotome (Reichert Ultracut E). The thick sections were stained with Toluidine Blue and examined by light microscopy. Ultrathin sections were stained with 4% uranyl acetate and lead citrate and then examined with an H-7650 transmission electron microscope (Hitachi, Tokyo, Japan).
Fluorescein angiography
Fluorescein angiography was recorded using a fundus camera (RC-2, Kowa, Aichi, Japan) with an external 66-diopter condensing lens mounted between the camera and the eye. The pupil was dilated with topical 1% tropicamide (Santen) and mice were injected intraperitoneally with 10% sodium fluorescein (Ak-Fluor, Akorn, IL) at a dose of 0.03 ml/5 g weight.
PBN treatment a-Phenyl-N-tert-butylnitrone (PBN), a commonly used free radical spin trap (Ranchon et al., 2003) , was purchased from Sigma-Aldrich (St. Louis, MO) and dissolved in saline. PBN (50 mg/kg) was intraperitoneally administered once daily for a week with light irradiation.
MCP-1 siRNA treatment
Transfection of MCP-1 siRNA (Santa Cruz Biotechnology, Inc.) was performed according to the manufacturer's instructions. ARPE-19 cells treated with MCP-1 siRNA were incubated in serum-free Dulbecco's modified Eagle's medium in the presence or absence of untreated phospholipids or oxidized phospholipids at concentrations of 0, 10, 25 or 50 mg/ml. After 6 hours, the medium was collected, filter sterilized and stored at 280˚C until use for ELISA for VEGF or PEDF. Each condition was evaluated in triplicate, and the results were repeated in at least three independent experiments.
Statistical analysis
All data are presented as means 6 s.d. and were compared using the Student's ttest. A P-value of less than 0.05 was considered statistically significant.
